BioSpace News Archive

ALR Technologies Inc. announced that it is taking steps to redomicile the Company to Singapore.

Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that Sergio Traversa , Chief Executive Officer of Relmada, is scheduled to participate in a fireside chat at Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 10:30 am Eastern Time

Selexis Appoints Roland Hoffmann- Hecht, PhD, as Chief Business Officer Business Development Executive in Biologics Drug Development and Manufacturing Brings More than 25 Years of Biopharmaceutical Industry Experience

TRxADE HEALTH, INC., a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., announced that its Board of Directors has authorized the repurchase of up to a maximum of $1.0 million of shares of the Company’s common stock.

The Red Cross and American Cancer Society kick off partnership as the need for lifesaving platelet donations intensifies during emergency shortage

According to our latest study on “Artificial Tears Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Delivery Mode, and Application,” the market was valued at US$ 2,612.91 million in 2020 and is projected to reach US$ 3,961.63 million by 2028; it is expected to grow at a CAGR of 5.5% from 2021 to 2028.

On the other hand, strict government guidelines and lack of knowledge about detailed examination are likely to have a negative impact on the growth of the market in the coming years.

The report highlights the trends prevailing in the market, and drivers and deterrents pertaining to the market growth.

According to our new research study on “Epithelial Cell Culture Media Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product Type and End User,” the market is expected to reach US$ 303,040.33 thousand by 2028 from US$ 128,155.95 thousand in 2020; it is estimated to grow at a CAGR of 11.4% from 2021 to 2028.

According to our new market research study on “Foot Orthotic Insoles Market – Global Analysis and Forecast – by Product Type, Material, Application, and Distribution Channel,” the global foot orthotic insoles market is expected to reach US$ 5,464.57 million by 2027 from US$ 3,560.00 million in 2019; it is estimated to grow at a CAGR of 5.7% from 2020 to 2027.